In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functio ns, tissues and cell types.
Join us for a 90-minute training session to learn more about the advanced features of QIAGEN IPA
In this 90-minute training, you’ll learn how to do drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands.
By attending this webinar, you will learn how to use QIAGEN Digital Insight’s enterprise solutions to extend the powerful QIAGEN CLC Genomics Workbench platform to tackle even the greatest bioinformatics challenges....
Multi-omics experiments allow researchers to make important discoveries in ways that have never before been possible. However, integrating these data into a broader biological context can be challenging and time consuming when using standard resources. At QIAGEN, we have introduced an innovative solution to this challenge: The market-leading QIAGEN Ingenuity Pathway A...
The study of the COVID-19 pandemic often involves sequencing the SARS-CoV-2 virus using Illumina, Nanopore, IonTorrent and Sanger technologies alone or in combination. Depending on the sampling and library preparation method used, this can involve metatranscriptomic data of varying viral content. In this webinar tutorial, you will learn about: Best practices for ...
QIAGEN offers two analysis solutions for data acquired using QIAseq Kits. The GeneGlobe Analysis Center is our web-based portal with fixed, ready-to-use pipelines, while QIAGEN CLC Genomics Workbench is our onpremise solution providing ready-to-use workflows, which are fully configurable. QIAGEN CLC Genomics Workbench is a user-friendly bioinformatics software solutio...
QIAGEN Ingenuity Pathway Analysis (IPA) reveals the hidden upstream drivers and downstream outcomes in your toxicogenomics datasets. Put those results into context using Analysis Match with over 50,000 pre-analyzed datasets for human, mouse and rat. Explain the causes and effects in your studies so you can generate hypotheses to develop better drugs, biomarkers and mo...
Join our webinar to discover a scalable workflow for SARS-CoV-2 whole genome sequencing to accelerate detection of variants such as B.1.1.7 and B.1.351. In this new webinar, we will describe how QIAGEN’s QIAseq SARS-CoV-2 integrated workflow combines QIAseq chemistries and CLC Genomics Analysis software to deliver a scalable, high-performance solution for sequencing...
Identifying and studying actionable variants is of great interest to many investigators. In this webinar, COSMIC, HGMD and QIAGEN database will be introduced for annotation and investigation of both somatic and germline variants. Attendees will learn how to use QIAGEN Clinical Insight Interpret Translational (QCI-IT) to identify key actionable variants from whole geno...
Watch this webinar to find out how you can simplify your NGS secondary analysis workflow to 5 easy steps using QCI Secondary Analysis, a new cloud-based service for NGS secondary analysis powered by DNAnexus®—the world’s most secure, trusted platform for biomedical data analysis. Scalable and workflow agnostic, QCI Secondary Analysis can be used with any NGS inst...
In this webinar presented by Rockefeller University, Danbury Hospital and QDI, we present a unique case study of a treatment-naïve patient with aggressive metastatic uLMS who has experienced long-term survival. Using whole exome sequencing (WES), we analyzed 5 tumors to identify mechanisms of uLMS tumor growth and metastasis in this patient. Attendees of this webi...
